{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:33:09Z","timestamp":1777321989575,"version":"3.51.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084259"],"award-info":[{"award-number":["OPP1084259"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018464","name":"European Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MR\/K021222\/1"],"award-info":[{"award-number":["MR\/K021222\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Serum Institute India Private Limited"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Salmonella Paratyphi A is a major cause of paratyphoid fever. Despite growing global concern, knowledge of S. Paratyphi A immunity remains limited, and no licensed vaccine exists. In a controlled human infection model (CHIM) homologous S. Paratyphi A rechallenge showed a non-significant reduction in risk of acute disease. This study evaluates humoral immunity following experimental S. Paratyphi A exposure and vaccination with a bivalent S. Typhi\u2013S. Paratyphi A conjugate vaccine (Sii-PTCV).<\/jats:p>\n                  <jats:p>Serum samples from 2 UK CHIM studies and a Phase I trial in India of Sii-PTCV were analyzed. S. Paratyphi A-specific IgG, serum bactericidal activity (SBA), antibody-dependent monocyte phagocytosis (ADMP), and neutrophil phagocytosis (ADNP) were measured pre and post-exposure or vaccination. Statistical differences were assessed using Wilcoxon matched-pairs signed rank test or the Mann\u2013Whitney test.<\/jats:p>\n                  <jats:p>Experimental challenge significantly increased IgG, SBA, ADMP, and ADNP (all P\u2009&amp;lt;\u20090.0001), with strongest responses in participants who developed systemic infection. No immune marker correlated with protection in rechallenged individuals. Baseline antibody levels were higher in the Indian cohort than in the United Kingdom (P\u2009=\u20090.0041), suggesting prior natural exposure enhances humoral immunity. Vaccination with Sii-PTCV induced significantly greater responses than challenge, particularly for IgG (P\u2009&amp;lt;\u20090.0001), SBA (P\u2009&amp;lt;\u20090.001), and ADMP (P\u2009&amp;lt;\u20090.001).<\/jats:p>\n                  <jats:p>This study highlights differences in S. Paratyphi A immunity between naive and exposed populations. Both challenge and vaccination with S. Paratyphi A elicited strong humoral responses, with vaccination producing higher magnitude responses. The bivalent vaccine shows promise for paratyphoid prevention, though a clear correlate of protection remains to be defined.<\/jats:p>","DOI":"10.1093\/jimmun\/vkag044","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:38:19Z","timestamp":1777318699000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of\n                    <i>Salmonella<\/i>\n                    Paratyphi specific antibody quantity and function after vaccination and controlled human infection"],"prefix":"10.1093","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-1001","authenticated-orcid":false,"given":"Elizabeth","family":"Jones","sequence":"first","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-4608","authenticated-orcid":false,"given":"Anna","family":"Beekmayer-Dhillon","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Day","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Dinesh","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarthak","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyeon","family":"Park","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mclean","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Flaxman","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonu","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Pantazi","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Gavade","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashekhar D","family":"Kamat","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirudha Vyankatesh","family":"Potey","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesh","family":"Bharati","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodkumar","family":"Haridasyam","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev M","family":"Dhere","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambhaji S","family":"Pisal","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Mallya","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad S","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt Ltd , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malick M","family":"Gibani","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London , London,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2026042715381163000_vkag044-B1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026042715381163000_vkag044-B2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026042715381163000_vkag044-B3","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1093\/ofid\/ofad077","article-title":"Genomic surveillance of Salmonella Paratyphi A: neglected no more?","volume":"10","author":"Hooda","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026042715381163000_vkag044-B4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/pathogens10040410","article-title":"Enteric fever diagnosis: current challenges and future directions","volume":"10","author":"Neupane","year":"2021","journal-title":"Pathogens"},{"key":"2026042715381163000_vkag044-B5","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"2026042715381163000_vkag044-B6","doi-asserted-by":"publisher","first-page":"S499","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: A Worldwide Review, 1990-2018","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026042715381163000_vkag044-B7","doi-asserted-by":"crossref","first-page":"e14417","DOI":"10.1111\/1751-7915.14417","article-title":"Climate change affects the spread of typhoid pathogens","volume":"17","author":"Jia","year":"2024","journal-title":"Microb Biotechnol"},{"key":"2026042715381163000_vkag044-B8","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.291.21.2607","article-title":"Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia","volume":"291","author":"Vollaard","year":"2004","journal-title":"J Am Med Assoc"},{"key":"2026042715381163000_vkag044-B9","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1016\/S2214-109X(22)00119-X","article-title":"Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project","volume":"10","author":"Garrett","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026042715381163000_vkag044-B10","doi-asserted-by":"crossref","first-page":"e74097","DOI":"10.1371\/journal.pone.0074097","article-title":"Stochastic simulation of endemic Salmonella enterica serovar typhi: the importance of long-lasting immunity and the carrier state","volume":"8","author":"Saul","year":"2013","journal-title":"PLoS One"},{"key":"2026042715381163000_vkag044-B11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/pgmj.48.556.98","article-title":"On vaccines and vaccination: typhoid-paratyphoid fevers","volume":"48","author":"Vella","year":"1972","journal-title":"Postgrad Med J"},{"key":"2026042715381163000_vkag044-B12","doi-asserted-by":"publisher","author":"Drysdale","DOI":"10.1017\/S0022172400013644"},{"key":"2026042715381163000_vkag044-B13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/vaccines11010091","article-title":"A bivalent MAPS vaccine induces protective antibody responses against Salmonella Typhi and Paratyphi A","volume":"11","author":"Zhang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2026042715381163000_vkag044-B14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2019.03.003","article-title":"Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902","volume":"201","author":"Wahid","year":"2019","journal-title":"Clin Immunol"},{"key":"2026042715381163000_vkag044-B15","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2016.03.106","article-title":"Status of paratyphoid fever vaccine research and development","volume":"34","author":"Martin","year":"2016","journal-title":"Vaccine"},{"key":"2026042715381163000_vkag044-B16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(23)02031-7","article-title":"Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children","volume":"403","author":"Patel","year":"2024","journal-title":"The Lancet"},{"key":"2026042715381163000_vkag044-B17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/IAI.68.3.1529-1534.2000","article-title":"Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"68","author":"Konadu","year":"2000","journal-title":"Infect Immun"},{"key":"2026042715381163000_vkag044-B18","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/ofid\/ofad041","article-title":"Salmonella combination vaccines: moving beyond typhoid","volume":"10","author":"MacLennan","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026042715381163000_vkag044-B19","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(24)00249-6","article-title":"The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial","volume":"403","author":"Kulkarni","year":"2024","journal-title":"Lancet"},{"key":"2026042715381163000_vkag044-B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201116","article-title":"Vi-specific serological correlates of protection for typhoid fever","volume":"218","author":"Jin","year":"2021","journal-title":"J Exp Med"},{"key":"2026042715381163000_vkag044-B21","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3389\/fimmu.2019.02582","article-title":"IgA and IgG1 specific to vi polysaccharide of salmonella typhi correlate with protection status in a typhoid fever controlled human infection model","volume":"10","author":"Dahora","year":"2019","journal-title":"Front Immunol"},{"key":"2026042715381163000_vkag044-B22","doi-asserted-by":"crossref","first-page":"e007481","DOI":"10.1136\/bmjopen-2014-007481","article-title":"Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers","volume":"5","author":"McCullagh","year":"2015","journal-title":"BMJ Open"},{"key":"2026042715381163000_vkag044-B23","doi-asserted-by":"crossref","first-page":"e0008783","DOI":"10.1371\/journal.pntd.0008783","article-title":"Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model","volume":"14","author":"Gibani","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2026042715381163000_vkag044-B24","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model","volume":"64","author":"Dobinson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026042715381163000_vkag044-B25","article-title":"A Salmonella Typhi controlled human infection study for assessing correlation between bactericidal antibodies and protection against infection induced by typhoid vaccination","volume":"28","author":"Jones","year":"2021","journal-title":"Microorganisms"},{"key":"2026042715381163000_vkag044-B26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fmicb.2014.00391","article-title":"Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ","volume":"5","author":"Gal-Mor","year":"2014","journal-title":"Frontiers in Microbiology"},{"key":"2026042715381163000_vkag044-B27","doi-asserted-by":"publisher","first-page":"e13306","DOI":"10.1111\/cmi.13306","article-title":"Very long O-antigen chains of Salmonella Paratyphi A inhibit inflammasome activation and pyroptotic cell death","volume":"23","author":"Mylona","year":"2021","journal-title":"Cell Microbiol"},{"key":"2026042715381163000_vkag044-B28","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.celrep.2018.01.016","article-title":"Mechanisms to evade the phagocyte respiratory burst arose by convergent evolution in typhoidal Salmonella serovars","volume":"22","author":"Hiyoshi","year":"2018","journal-title":"Cell Rep"},{"key":"2026042715381163000_vkag044-B29","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in south Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2026042715381163000_vkag044-B30","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/ofid\/ofad021","article-title":"Seroepidemiology for enteric fever: emerging approaches and opportunities","volume":"10","author":"Aiemjoy","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026042715381163000_vkag044-B31","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/CVI.00245-09","article-title":"Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal","volume":"16","author":"Pulickal","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"2026042715381163000_vkag044-B32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.vaccine.2014.11.030","article-title":"Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral VI capsular polysaccharide typhoid vaccines administered concomitantly","volume":"33","author":"Pakkanen","year":"2015","journal-title":"Vaccine"},{"key":"2026042715381163000_vkag044-B33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CVI.00058-12","article-title":"Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica Serovar Paratyphi A and S. Paratyphi B in humans","volume":"19","author":"Wahid","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"2026042715381163000_vkag044-B34","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2012.07.051","article-title":"Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination","volume":"30","author":"Pakkanen","year":"2012","journal-title":"Vaccine"},{"key":"2026042715381163000_vkag044-B35","author":"Organization, W. H","year":"2025"},{"key":"2026042715381163000_vkag044-B36","author":"Organization, W. H","year":"2025"},{"key":"2026042715381163000_vkag044-B37","author":"WHO technical report series, No. 1004","year":"2017"},{"key":"2026042715381163000_vkag044-B38","author":"WHO, Typhoid vaccines: WHO position paper - March 2018","year":"2018"},{"key":"2026042715381163000_vkag044-B39","author":"WHO","year":"2024"},{"key":"2026042715381163000_vkag044-B40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fitd.2021.742804","article-title":"Association of antibody-dependent neutrophil phagocytosis with distinct antibody glycosylation profiles following typhoid vaccination","volume":"2","author":"Johnson","year":"2021","journal-title":"Front Trop Dis"},{"key":"2026042715381163000_vkag044-B41","doi-asserted-by":"publisher","first-page":"e0041923","DOI":"10.1128\/MSPHERE.00419-23","article-title":"Oral immunization with Shigella sonnei WRSs2 and WRSs3 vaccine strains elicits systemic and mucosal antibodies with functional anti-microbial activity","volume":"9","author":"Shrivastava","year":"2023","journal-title":"mSphere"},{"key":"2026042715381163000_vkag044-B42","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/4\/vkag044\/68171596\/vkag044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/4\/vkag044\/68171596\/vkag044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:38:23Z","timestamp":1777318703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkag044\/8663634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkag044","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,4]]},"article-number":"vkag044"}}